There are heros in our society today and there are unsung heros in our society today. It seems like the people who do absolutely nothing for society gets the credit. On the other hand, the people who dedicate their lives to fight a cause seem to get swept under the rug and forgotten. Unfortunately, this is the kind of society that we live in. Clay Siegall, Ph.D., M.D., is the man of the hour. He is one of the most progressive-thinking individuals in cancer research. Dr. Siegall’s path to greatness started out many decades ago. He has worked exclusively with high-profile names such the National Institute of Health and the National Cancer Institute. Lets take a closure look at to why this man is so special.
Dr. Siegall’s profound understanding of cancer actually comes from his educational background. He has a Ph.D. in Genetics as well as a B.S. in Zoology. Siegall received these accreditations from the affluent George Washington University and from the University of Maryland. “I’ve always been interested in medicine,” said Siegall. He has a knack for trying to restore the health of people who have been suffering with cancer. This man is what you would call an “old guard.” Seattle Genetics is his weapon of choice, and this oncology company has a successful track record. Seattle Genetics specializes in developing and commercializing antibody-drug conjugates. These advanced medications do a great of attaching themselves to cancer cells in the body. Once the ADCs are attached, they’ll deliver a cell-killing blow of magnitude proportions.
By being able to enter the medications into multiple strategic licenses, the medications can now be used all around the globe. Dr. Siegall has worked on deals with Bayer, with Pfizer, with GlaxoSmithKlien and with Genentech to make this possible. Is there anything that this man can’t do as it pertains to cancer research? In the end, he may not be a household name, but Dr. Clay Siegall has helped to reshape society from the inside out.